🔗 Permalink

Inventor profile of:

Ellalahewage Sathyajith Kumarasinghe

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2026-01-15

Top Assignees for applications by Ellalahewage Sathyajith Kumarasinghe

The entities that hold a legal rights for patent applications filed by inventor Kumarasinghe Ellalahewage Sathyajith:

ModernaTX, Inc. 14 Cambridge, MA United States

Recent patent applications by Kumarasinghe Ellalahewage Sathyajith

Ellalahewage Sathyajith Kumarasinghe from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-15

US20260014281A1

Human necessities

PEG TARGETING COMPOUNDS FOR DELIVERY OF THERAPEUTICS

#2 | 2024-09-26

US20240318187A1

Chemistry; metallurgy

POLYRIBONUCLEOTIDES CONTAINING REDUCED URACIL CONTENT AND USES THEREOF

#3 | 2024-04-18

US20240124388A1

Chemistry; metallurgy

Compounds and compositions for intracellular delivery of therapeutic agents

#4 | 2024-01-25

US20240024422A1

Human necessities

POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF

#5 | 2023-11-02

US20230346928A1

Human necessities

MRNA COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#6 | 2023-10-12

US20230323371A1

Chemistry; metallurgy

POLYNUCLEOTIDES ENCODING ALPHA-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE

#7 | 2023-02-09

US20230041964A1

Human necessities

COMBINATIONS OF MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF

#8 | 2023-01-26

US20230026381A1

Human necessities

Combinations of mRNAs encoding immune modulating polypeptides and uses thereof

#9 | 2022-03-10

US20220071915A1

Human necessities

Polynucleotides encoding Citrin for the treatment of Citrullinemia type 2

#10 | 2021-09-02

US20210269830A1

Chemistry; metallurgy

Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1

#11 | 2020-03-19

US20200085916A1

Human necessities

POLYNUCLEOTIDES ENCODING PORPHOBILINOGEN DEAMINASE FOR THE TREATMENT OF ACUTE INTERMITTENT PORPHYRIA

#12 | 2019-12-26

US20190390181A1

Chemistry; metallurgy

Polynucleotides encoding lipoprotein lipase for the treatment of hyperlipidemia

#13 | 2019-12-19

US20190382774A1

Chemistry; metallurgy

POLYRIBONUCLEOTIDES CONTAINING REDUCED URACIL CONTENT AND USES THEREOF

#14 | 2019-10-03

US20190300906A1

Chemistry; metallurgy

Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1

#15 | 2019-10-03

US20190298658A1

Human necessities

Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis

#16 | 2019-10-03

US20190298657A1

Human necessities

Polynucleotides Encoding Acyl-CoA Dehydrogenase, Very Long-Chain for the Treatment of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency

#17 | 2019-06-13

US20190175517A1

Human necessities

Polynucleotides encoding citrin for the treatment of Citrullinemia type 2

#18 | 2017-08-17

US20170233332A1

Chemistry; metallurgy

Compounds and compositions for intracellular delivery of therapeutic agents

#19 | 2017-08-10

US20170224844A1

Human necessities

Compounds and compositions for intracellular delivery of therapeutic agents

#20 | 2017-07-27

US20170210698A1

Chemistry; metallurgy

Compounds and compositions for intracellular delivery of therapeutic agents

#21 | 2017-07-27

US20170210697A1

Chemistry; metallurgy

Compounds and compositions for intracellular delivery of therapeutic agents

InventorID:

1938995 ⎘